Secondary Sale
The sale of existing company shares from one shareholder to another, generating no new capital for the company itself.
A secondary sale transfers already-issued shares from an existing shareholder (a founder, employee, or early investor) to a new buyer, as opposed to a primary sale where the company issues brand-new shares in exchange for capital that goes onto its own balance sheet. Secondaries give shareholders liquidity — cash in hand — without requiring the company itself to raise or spend money.
Secondaries can happen individually (a single founder or employee selling some shares to an interested investor) or as an organized company-facilitated tender offer covering many shareholders at once, and they're typically subject to a right of first refusal and tag-along/drag-along provisions that give the company and other investors some control over who ends up owning shares.
Secondaries also happen at the fund level. In an LP secondary, a limited partner sells its interest in a venture fund to another investor; in a GP-led secondary, the manager moves one or more portfolio companies into a new vehicle, often called a continuation fund, so existing LPs can cash out or roll over. Both have become standard portfolio-management tools rather than distress signals.
Most startup transfers need company sign-off. Stock agreements standardly include a right of first refusal for the company (and often investors), co-sale rights, and transfer restrictions that can require board consent. Prices set in secondary trades can also feed into 409A valuations and employee expectations, which is part of why companies watch them closely.
Secondary buyers often price at a discount to the last primary round to reflect illiquidity, the lack of fresh control rights, and the risk that the last round was aspirational. The most sought-after companies can trade at or above the last round price.
A Series B investor holds 2,000,000 shares bought at $5.00 ($10M). Four years later, with no IPO in sight, a secondary fund offers $7.50 per share. The investor sells for $15M — a 1.5x return it can distribute to its own LPs — and the buyer steps onto the cap table, subject to the company's right of first refusal. The company itself receives nothing.
Founders and early employees should consider a modest, well-timed secondary sale at a growth-stage round to reduce personal financial risk — taking some chips off the table doesn't have to signal a lack of conviction, and it can actually reduce pressure to force a premature company-level exit.
Does a secondary sale bring new money into the company?
No — the cash goes directly to the selling shareholder, not the company's balance sheet, since existing shares are simply changing hands rather than new shares being issued.
Do secondary sales require company approval?
Almost always. Startup stock agreements usually give the company a right of first refusal and impose transfer restrictions, and many require board consent. Check the transfer provisions before agreeing on a price, not after.
Why would a buyer pay less than the last round valuation in a secondary?
Common shares sold in secondaries lack the preferred rights of a primary round, they're illiquid, and the last round price may have been aspirational. Buyers price those risks in with a discount, which varies widely by company.
Is selling in a secondary a sign a company is in trouble?
Not as a rule. Institutions now use secondaries routinely to manage liquidity. Context still matters, though — a founder selling a large personal stake outside any organized process will raise questions.
Related terms
Run the numbers yourself: dilution, SAFE conversion, and fund-returner calculators.